Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
The 2026-2031 World Outlook for Cancer Gene Therapies
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Advanced Therapy Medicinal Products
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
mRNA Vaccines and Therapeutics Market Report by Vaccine Type (Self-amplifying mRNA-Based Vaccines, Conventional Non-Amplifying mRNA-Based Vaccines), Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, and Others), Vaccine Manufacturing (In-House, Out-Sourced), Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement), End-User (Hospitals and Clinics, Research Organizations, and Others), and Region 2025-2033
... during 2025-2033. The development and acceptance of mRNA-based vaccines on a global scale, the growing need for quick and adaptable solutions for emerging and re-emerging infectious diseases, and the increasing incidence of cancer and genetic ... Read More
-
Drug and Gene Delivery Devices
... Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Oral, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$510.3 Million by ... Read More
-
Viral Vector Manufacturing
... at a CAGR of 18.3% over the analysis period 2024-2030. Retroviral Vectors, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$954.6 Million by the end of ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Gene Therapy
... CAGR of 23.0% over the analysis period 2024-2030. Viral, one of the segments analyzed in the report, is expected to record a 23.3% CAGR and reach US$5.5 Billion by the end of the analysis period. ... Read More
-
Epigenetics
... 18.2% over the analysis period 2024-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth ... Read More
-
Autologous Cell Therapies
... at a CAGR of 18.0% over the analysis period 2024-2030. Neurology, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$26.1 Billion by the end of the ... Read More
-
Viral Inactivation
... CAGR of 11.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$865.8 Million by the end of the ... Read More
-
Expression Vectors
... CAGR of 5.4% over the analysis period 2024-2030. Bacterial Expression Vectors, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$362.4 Million by the end of the ... Read More
-
Cell And Gene Therapy CDMO Market Size, Share & Trends Analysis Report By Phase (Pre-clinical, Clinical), By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases), By Region, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... the forecast period from 2024 to 2033. Key Takeaways: North America accounts for the largest share of 40.18% in 2023. Asia Pacific, on the other hand, is anticipated to register a lucrative CAGR of 29.1% ... Read More
-
Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Therapy Type, By Scale (R&D), By Mode, By Workflow (Vector Production, Cell Banking), By Region, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... the forecast period from 2024 to 2033. Key Takeaways: North America accounted for the highest revenue share of 48.32% in 2023. Asia Pacific is anticipated to be a growing market for cell and gene therapy ... Read More
-
U.S. Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy Manufacturing, Gene therapy manufacturing), By Scale, By Mode, By Workflow, And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
... annual growth rate (CAGR) of 27.2% during the forecast period 2024 to 2033. Key Takeaways: The cell therapy manufacturing segment dominated the market with a revenue share of 56.12% in 2023. The gene therapy segment ... Read More
-
U.S. Cell And Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Site Identification, Patient Recruitment), By Phase (Phase I, Phase II), By Therapeutic Areas, By Therapy Type, And Segment) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
... over the forecast period of 2024 to 2033. Key Takeaways: The regulatory services segment held the largest revenue share of 21.34% in 2023. The supply and logistic services segment is anticipated to register a considerable ... Read More
-
Innovative Medicine Market, By Therapy Type (Immunotherapy, Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule Therapy, Biologic Therapy, RNA-Based Therapy, Progenitor Cell Therapy, Peptide-Based Therapy, Microbiome Therapy, Antisense Oligonucleotide Therapy, CRISPR-based Therapy, mRNA-based Vaccines, and Monoclonal Antibodies), By Application (Oncology, Neurology, Cardiology, Ophthalmology, Dermatology, Musculoskeletal Disorders, Immunology & Inflammation, Genetic Disorders, Infectious Diseases, Metabolic Disorders, Hematology, Rare Diseases, Gastroenterology, and Others), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular, Topical, and Inhalation), By End User (Hospitals & Clinics, Academic & Research Institutes, Specialty Centers, Ambulatory Surgical Centers, Government & Regulatory Bodies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Innovative medicines, also known as specialty drugs or biopharmaceuticals, are advanced medical treatments that offer new and improved therapeutic options for various diseases. These medicines are developed using cutting-edge technologies and are designed to target ... Read More
-
2025 Global Forecast for Lentiviral Vector In Gene Therapy Market (2026-2031 Outlook)-High Tech Outlook Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Cell & Gene Therapies in Dermatology Disorders: Therapeutic Analysis
... indicated for the treatment of burns in pediatric and adult patients, was the first autologous keratinocyte cell-based therapy to receive approval in the dermatology market in 2006, by the Ministry of Food and Drug Safety ... Read More
-
Global Gene Therapy Market - 2025-2033
... period 2025-2033. Gene Therapy Market Overview The gene therapy market is experiencing rapid growth, driven by advancements in genomics, biotechnology and personalized medicine. Gene therapy is revolutionizing genetic disorders, rare diseases and cancer treatments. The ... Read More
-
2024 Cell and Gene: Research Review
... trials, the production of therapies, viral vectors, modified cells, and personalized medicine. One of the major factors in this market's growth is the increasing investment and funding. The rapid growth in research and development of ... Read More
-
2025 Global: Gene Therapy For Cancer Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Gene Therapy For Ovarian Cancer Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
2025 Global: Gene Therapy For Mucopolysaccharidosis Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Gene Therapy For Heart Failure Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
Viral Vectors And Plasmid DNA Global Market Report 2025
... vectors and plasmid dna market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
Research Assistance
